Sandbox: wdx causes: Difference between revisions
Jump to navigation
Jump to search
Line 5: | Line 5: | ||
{| | {| | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ||
! | ! rowspan="5" |Disease | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
! colspan="3" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mechanism | ! colspan="3" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mechanism | ||
Line 15: | Line 15: | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|- | |- | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ||
Line 21: | Line 20: | ||
| colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Signs | | colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Signs | ||
|- | |- | ||
! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ||
|- | |- | ||
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever | ! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rash | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rash | ||
Line 40: | Line 37: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow infiltration | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow infiltration | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow failure | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow failure | ||
Line 82: | Line 78: | ||
! | ! | ||
|- | |- | ||
! | !Malignancies such as: | ||
* Acute leukemias | * Acute leukemias | ||
* Chronic leukemias | * Chronic leukemias | ||
* Multiple myeloma | * Multiple myeloma | ||
* Metastatic cancer | * Metastatic cancer | ||
Line 173: | Line 169: | ||
|- | |- | ||
!Aplastic anemia | !Aplastic anemia | ||
!Immune destruction | !Immune destruction | ||
! | ! | ||
!+ | !+ | ||
Line 200: | Line 196: | ||
! | ! | ||
|- | |- | ||
! | !Paroxysmal nocturnal hemoglobinuria | ||
!Immune destruction | |||
! | |||
!+ | |||
! | ! | ||
! | ! | ||
! | ! | ||
! | ! | ||
! | ! | ||
! | ! | ||
Line 225: | Line 223: | ||
! | ! | ||
! | ! | ||
|- | |||
!Disseminated intravascular coagulation | |||
!Consumption | |||
! | ! | ||
! | ! | ||
!+ | |||
! | |||
! | ! | ||
! | ! | ||
! | ! | ||
! | ! | ||
! | ! | ||
! | ! | ||
Line 252: | Line 251: | ||
! | ! | ||
! | ! | ||
|- | |||
!Dyskeratosis congenital/telomere biology disorders | |||
! | ! | ||
! | ! | ||
! | ! | ||
! | ! | ||
!+ | !+ | ||
Line 281: | Line 279: | ||
! | ! | ||
! | ! | ||
|- | |||
!Shwachman-Diamond syndrome | |||
! | ! | ||
! | ! | ||
! | ! | ||
! | ! | ||
!+ | !+ | ||
! | ! | ||
! | ! | ||
Line 690: | Line 686: | ||
* Cytotoxic drugs | * Cytotoxic drugs | ||
* Idiosyncratic reactions to medications | * Idiosyncratic reactions to medications | ||
!Immune destruction | !Immune destruction | ||
! | ! | ||
!+ | !+ |
Revision as of 03:15, 28 August 2018
Differentiating Pancytopenia from Other Diseases
- Pancytopenia must be differentiated from a pseudo-syndromes like pseudo-thrombocytopenia, which is a laboratory artifact from platelet clumping.
- There are no other mimickers of pancytopenia, as the diagnosis can be unequivocally established by laboratory testing (complete blood count).
Category | Disease | Etiology | Mechanism | Congenital | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | ||||||||||||||||||||||||
Lab Findings | Imaging | ||||||||||||||||||||||||||
Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other | CBC | PBS | Bone marrow exam | PT | PTT | UA | |||||||||||||||
Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Plt | HB | WBC | ||||||||||||||||||||||
Hematologic disorders | Myelodysplastic syndromes (MDS) |
|
|||||||||||||||||||||||||
Malignancies such as:
|
|
+ | + | + | |||||||||||||||||||||||
Myelofibrosis | Bone marrow infiltration | + | |||||||||||||||||||||||||
Fanconi anemia | + | ||||||||||||||||||||||||||
Aplastic anemia | Immune destruction | + | |||||||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria | Immune destruction | + | |||||||||||||||||||||||||
Disseminated intravascular coagulation | Consumption | + | |||||||||||||||||||||||||
Dyskeratosis congenital/telomere biology disorders | + | ||||||||||||||||||||||||||
Shwachman-Diamond syndrome | + | ||||||||||||||||||||||||||
Immunology/
Rheumatology |
SLE | ||||||||||||||||||||||||||
Felty syndrome | |||||||||||||||||||||||||||
Wiskott Aldrich syndrome | + | ||||||||||||||||||||||||||
GATA2 deficiency | + | ||||||||||||||||||||||||||
Hemophagocytic lymphohistiocytosis (HLH) | + | ||||||||||||||||||||||||||
GI disorders | Portal hypertension/cirrhosis | Splenomegaly | + | ||||||||||||||||||||||||
Storage diseases (eg, Gaucher) |
|
+ | + | ||||||||||||||||||||||||
Infections | Sepsis | Bone marrow infiltration | + | ||||||||||||||||||||||||
Viral infection such as HIV, hepatitis, Epstein-Barr virus |
|
+ | + | ||||||||||||||||||||||||
Nutritional | Megaloblastic anemia | Ineffective hematopoiesis | + | ||||||||||||||||||||||||
Excessive alcohol | Ineffective hematopoiesis | ||||||||||||||||||||||||||
Other (eg, copper deficiency, zinc toxicity) | Ineffective hematopoiesis | ||||||||||||||||||||||||||
Malnutrition | Ineffective hematopoiesis | ||||||||||||||||||||||||||
Medications | Medications such as:
|
Immune destruction | + | ||||||||||||||||||||||||
Category | Etiology | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Congenital | Acquried | Demography | History | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings |